Special approvals of the Federal Institute for Drugs and Medical Devices for the distribution of medical devices and FFP breathing masks without an expiration valve
Restrictions for patents owners to preserve the public interest in the sufficient availability of necessary medicinal products
GDPR and life sciences – part 2
Personal protective equipment COVID-19 export restrictions
GDPR and private sector life sciences
National perspectives on the CJEU Bayer decision
Medical devices and managing product liability risks
Taking a new approach to European patent law